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Summary Background: Acupuncture and homeopathy are commonly used comple-
mentary treatments for chronic asthma. This review summarizes two recently
updated Cochrane systematic reviews that assess the safety and efficacy of
homeopathy or acupuncture in individuals with chronic stable asthma.
Inclusion criteria: Only randomized-controlled trials were considered for inclu-
sion. Statistical aggregation of the data was undertaken where possible.
Search strategy: Searches for both reviews were done with the assistance of the
Cochrane Airways Group, and through electronic alerts.
Results: Acupuncture: 11 studies with 324 participants met the inclusion criteria.
Trial reporting was poor, and the trial quality was deemed inadequate to generalize
the findings. There was variation in the type of active and sham acupunctures, the
outcomes assessed and the time points measured. The points used in the sham arm
of some studies are used for the treatment of asthma according to traditional
Chinese medicine. Two studies used individualized treatment strategies, and one
study used a combination strategy of formula acupuncture with the addition of
individualized points. No statistically significant or clinically relevant effects were
found for acupuncture compared with sham acupuncture. When data from two small
studies were pooled, no difference in lung function was observed (post-treatment
FEV1): standardized mean difference 0.12, 95% confidence interval 0.31 to 0.55).
Conclusion: Acupuncture: There is not enough evidence to recommend the use of
acupuncture in the treatment of asthma. Further research needs to be undertaken,
and this should take into account the different types of acupuncture practiced.
Results: Homeopathy: Six trials with a total of 556 people were included in the
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review. These trials were all placebo-controlled and double-blind, but were of
variable quality. Standardized treatments in these trials are unlikely to represent
common homeopathic practice where treatment tends to be individualized. The
results of the studies are conflicting in terms of effects on lung function. There has
been only a limited attempt to measure a ‘‘package of care’’ effect (i.e. the effect
of the medication as well as the consultation, which is considered a vital part of
individualized homeopathic practice).
Conclusion: Homeopathy: There is not enough evidence to reliably assess the
possible role of homeopathy in the treatment of asthma. Further studies could assess
whether individuals respond to a ‘‘package of care’’ rather than the homeopathic
intervention alone.
& 2004 Elsevier Ltd. All rights reserved.
Background
Bronchial asthma is a major health problem and is
associated with significant morbidity. The reported
prevalence of asthma in children ranges from
1.6%–35% in different countries, whereas the
prevalence of asthma symptoms in adults ranges
from 4.1%–32% in Europe.1 Although the symptoms
can be controlled by drug treatment in most
patients, effective low-risk, non-drug strategies
would provide a valuable adjunctive or alternative
treatment in asthma management.
There is much interest in complementary and
alternative medicine (CAM), and its use is growing
at a significant rate.2 The term CAM covers a large
number of therapies, sometimes with no apparent
connection, as they can often have diverse origins,
theories, and appearances. There are no hard and
fast definitions of what exactly constitutes CAM,
but a good practical definition is ‘‘interventions
neither taught widely in medical schools nor
generally available in hospitals’’.3 Although the
use of CAM can be the result of dissatisfaction with
conventional treatment,4 it can also be an expres-
sion of taking personal responsibility in dealing with
chronic illness.5 Two common types of CAM used by
people with asthma are homeopathy and acupunc-
ture. In one survey, 9% of responders had used
homeopathy and 5% had used acupuncture in the
previous year.6
Acupuncture
Acupuncture is a form of therapy derived from
traditional Chinese medicine, which involves the
stimulation of points on the body with the use of
needles for therapeutic or preventative purposes.
As the use of acupuncture has become more
prevalent in the West, these theories have been
developed to fit in with a Western understanding of
bodily function.7 Other methods of stimulation
have been used, such as the use of pressure
(acupressure) and, more recently, the use of lasers.
One important but under-researched aspect of
treatment is the subjective element of this com-
plex therapy. It is difficult to remove acupuncture
treatment from its context, and this has not been
addressed in existing research.
Homeopathy
Homeopathy is one of the most widespread and
controversial forms of complementary or alterna-
tive medicine. Surveys among general practitioners
and chest physicians suggest that a significant
proportion might seek additional advice from
homeopaths.8,9
Homeopathy is based on the principle of ‘‘like
curing like’’ (similia similibus curentur): a prepara-
tion that would cause certain symptoms is used to
cure those symptoms. Homeopathic remedies are
prepared as ‘‘potencies’’, with several consecutive
dilutions with vigorous shaking (succussion) be-
tween each dilution step. The molecules contained
in a homeopathic remedy are diluted beyond
Avogadro’s number. This has led some investigators
to question whether homeopathic therapy could
have any effect over placebo.10 However, propo-
nents of homeopathy claim that the remedies act
through biophysical pathways, and all include the
idea of some form of information transfer from the
diluted substance to the diluting agent.11–14
At least four basic types of homeopathy are
differentiated in this review. For chronic diseases
such as asthma, the ‘‘classical’’ homeopathic
approach is probably most widespread. In classical
homeopathy, the choice of the remedy is deter-
mined by the individual symptoms of each patient.
As a consequence, different asthma patients might
receive very different remedies, fitting their
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individual symptom patterns. Classical homeopathy
involves detailed and intense history taking, which
might give rise to significant non-specific ‘‘package
of care’’ effects. ‘‘Clinical’’ homeopathy, by con-
trast, uses the same remedy in patients presenting
with a relatively homogeneous pathology or con-
stellation of symptoms.
In some conditions (e.g. atopic asthma), a
diluted causative agent (e.g. potentized pollen)
may be used. This is called ‘‘isopathy’’. The use of
fixed combinations of several homeopathic reme-
dies (so-called ‘‘complex’’ remedies or ‘‘complex
homeopathy’’) for one or a limited number of
conditions is popular among general practitioners
or ‘‘beginners’’ of homeopathy, and is particularly
widespread in Europe, especially Germany and
France.
The objective of this overview is to summarize
two recently published Cochrane reviews.15,16 In
these reviews, we evaluated the evidence for the
efficacy of acupuncture and (separately) homeop-
athy for the treatment of patients with stable
chronic asthma. These reviews15,16 can be referred
to for more detailed information. We have detailed
the methodology common to both reviews, and
have then reported the findings of each review
separately. A summary of common conclusions is
provided at the end.
Methods common to both reviews
We identified studies assessing the effects of
acupuncture or homeopathy for chronic asthma.
Our inclusion criteria were as follows: randomized-
controlled trials, patients of any age with stable
chronic asthma or asthma-like symptoms, and a
treatment duration of over 1 week (to exclude
patients with acute asthma or studies that only
assessed short-term effects). The control treat-
ments included no treatment (other than conven-
tional asthma medicines), sham or placebo
acupuncture, or homeopathy and active compara-
tor interventions. Our primary outcome was lung
function. Other outcomes considered important
were medication use, quality of life, symptoms,
exacerbations, and global assessment of effective-
ness. The Jadad17 scale was used to rate the quality
of reporting of included trials.
Two reviewers assessed the search results and
determined whether studies met the inclusion
criteria. We extracted data and calculated effect
size with RevMan Version 1.0.1 (Cochrane Colla-
boration, Oxford, UK). For dichotomous or binary
data (e.g. admission to hospital), we used a fixed-
effects model and relative risk was calculated. For
continuous data (e.g. lung function), we used a
fixed-effects model and weighted mean difference
was calculated. Continuous data measured on
different metrics (e.g. % predicted and L/min)
were pooled using a standardized mean difference
(SMD). Two reviewers assessed concealment of
randomization, blinding of patients and evaluators,
and likelihood of selection bias after randomization
(whether intention-to-treat analysis was carried
out). We stratified the data on the basis of age
(adults vs children). Data from parallel and cross-
over studies were separated.
The acupuncture review
Method
For the acupuncture review, we searched the
Asthma and Wheez* register of the Cochrane
Airways Group and the Alternative Medicine Elec-
tronic Database from the British Library, in August
2003, for all trials including the following words:
acupuncture OR acupressure OR (electric* AND
stimulation) OR electrostimulation OR laser ther-
apy OR tens OR (electro* AND acupuncture)
Additionally, we checked the trial database of
the Cochrane field for complementary medicine
and reference lists of published reviews. Additional
hand searching was carried out. We established
automated citation alerts and contacted trialists
and researchers in the field of complementary and
alternative medical research.
Inclusion criteria
Trials included those in which needles were
inserted at acupuncture points or other defined
points for therapeutic purposes, or those in which
defined acupuncture points were stimulated in
another way, such as pressure or using a laser.
We determined the extent to which the sham
acupuncture could be construed as an active
stimulation of non-acupuncture points or whether
it did not involve any points. Studies in which
stimulation of active points was compared with no
stimulation of the same points (potentially a
double-blind study) were analysed separately from
studies in which stimulation of active points was
compared with stimulation of non-active points.
Results
Eleven studies were included and these are
detailed in Table 1.
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Table 1 Studies included in the acupuncture systematic review.
Reference Design and study
schedule
Methodological
quality (Jadad score)n
Participants Outcomes Results
Biernacki and
Peake27
Cross-over: 2 months
run-in, treatment on 1
day, follow-up 2 weeks,
then crossed over
1-1-1 23 Pulmonary function (30, 60min
and 2 weeks after treatment),
quality of life (2 weeks after
treatment) and rescue
medication usage (average of
daily use for 2 weeks after
treatment)
No overall significant difference
between real and sham on objective
outcome measures
Christensen
et al.25
Parallel group: 11 weeks
(2 weeks baseline period)
2-2-0 18 Pulmonary function, subjective
symptoms, drug use at 2, 0, 2,
5 and 9 weeks. IgE levels at 0, 5
and 9 weeks
All results seem to favour
acupuncture but, because of the small
sample size, definite conclusions
cannot be drawn
Dias et al.30 Parallel group: varying
observation periods for
different patients (2–12
weeks)
1-2-0 20 Pulmonary function, drug use,
subjective assessment (before
and after acupuncture
treatment)
Results seem to favour sham
acupuncture but, because of small
sample size and methodological flaws,
definite conclusion cannot be drawn
Hirsch and
Leupold20
Cross-over: 5 weeks each
phase, no washout
0-2-1 39 Peak flow, subjective symptoms
and drug use recorded daily by
the patient. Spirometry and
provocation test before and
after each treatment phase
Overall, no significant differences
between the groups
Joos et al.23 Parallel group: 4 weeks
baseline, 4 weeks
treatment, and 12 weeks
follow-up
1-0-1 38 Pulmonary function, drug use,
subjective assessment,
immunologic parameters
No significant changes in lung
function, significant reduction of drug
use in both groups (more in correct
acupuncture group)
Malmstr .om
et al.28
Parallel group: run-in up
to 12 weeks, 15 weeks
treatment, followed-up 2
weeks after final
treatment
2-0-1 27 Published: pulmonary function
(induced attack); Unpublished:
pulmonary function (at set
points) and drug use
No significant effect of treatment
reported in bronchial responsiveness
to induced attack
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Medici et al.22 Parallel group: 8 weeks
treatment, 8 week
break, 8 weeks
treatment, then follow-
up at 40 weeks
1-1-1 66 Pulmonary function, subjective
symptoms, drug use,
immunologic parameters
Significant results in favour of
acupuncture in PEF variability; by 10
months the differences between the
groups had disappeared
Mitchell and
Wells24
Parallel group: 38 weeks
(plus 4 weeks baseline)
1-2-0 31 Pulmonary function, drug use
and subjective symptoms
No significant differences between
groups
Shapira et al.29 Cross-over: 1 week
treatment, 3 week wash-
out/follow-up, then
crossed over, 3 week
follow-up
1-1-1 23 Pulmonary function, drug use
and subjective symptoms
No significant change in lung
functions, bronchial hyper-reactivity
or patient symptoms
Tandon et al.19 Cross-over: 3 weeks
baseline, 5 weeks
treatment 1, 3 weeks
wash-out, 5 weeks
treatment 2
2-2-0 15 Pulmonary function, drug use,
symptom score and treatment
preference
No significant effects between or
within groups
Tashkin et al.26 Cross-over: 4 weeks
baseline, 4 weeks
treatment 1, 3 weeks
wash-out, 4 weeks
treatment 2, 3 weeks
follow-up
1-2-0 25 Pulmonary function, subjective
measurements, drug use,
number of attacks
No significant differences between or
within groups
PEF, peak expiratory flow.
nJadad scores17 reflect the points awarded for the three component domains in the order of: randomization (0, 1 or 2), blinding (0, 1 or 2) and withdrawals (0 or 1).
Tw
o
co
ch
ran
e
syste
m
a
tic
re
vie
w
s
o
f
co
m
p
le
m
e
n
tary
tre
atm
e
n
ts
fo
r
ch
ro
n
ic
asth
m
a
691
Asthma was defined as reversible airways ob-
struction. Criteria varied between trials, with four
trials using guidelines for the definition of asthma:
either ATS18 criteria,19,20 GINA21 criteria,22 or
Deutsche Atemwegsliga criteria.23 Other trialists
used a measure of lung function24–29 or poor
response to Western drugs30 as inclusion criteria.
All studies recruited adult participants with the
exception of one study,20 which included children
only. Another study recruited a mixed population.26
Although it was not clear in all cases, we have
assumed that all participants were outpatients
drawn from a variety of hospital settings.
Severity of asthma was mild to moderate in all
studies except one,26 which recruited participants
with ‘‘moderate to severe’’ asthma.
We analysed laser and needle acupuncture sepa-
rately. The two laser acupuncture studies19,20 used
sham acupuncture with the lasers switched off.
No study explicitly described the method of
randomization. All trials attempted to blind pa-
tients and evaluators except for two studies,23,28 in
which only the patients were blinded. Although the
description of drop-outs and withdrawals was
adequate in six studies,20,22,23,27–29 no study re-
ported the results of an intention-to-treat popula-
tion. The experience and training of the
acupuncture therapist was unclear in most studies.
Needle acupuncture versus sham needle
acupuncture
A number of studies20,22–27,29,30 measured lung
function at varying time points. Data were pooled
for FEV1 after treatment with acupuncture or sham,
and no significant difference was observed (SMD
0.12, 95% CI 0.31 to 0.55).27,29 All the remaining
studies reported non-significant differences.
Seven of the eight needle acupuncture studies
attempted to monitor drug use,25–30 but there were
important differences in monitoring and assess-
ment methods. Two trials23,25 found statistically
significant decreases in medication usage vs sham
treatment, although values were only reported in
one study.23
Two trials measured perceived improvement in
overall wellbeing,23,30 with no significant differ-
ence between sham and active acupuncture for the
likelihood of improvement (RR: 1.13, 95% CI 0.51–
2.51). One study27 reported scores on the Asthma
Quality of Life Questionnaire, and detected a
significant improvement after treatment in both
groups (active treatment: P ¼ 0:003; sham treat-
ment: P ¼ 0:005).
Symptoms were measured in four studies.24–26,29
No significant differences between treatment and
sham acupuncture were observed in three of
these.24,26,29 The fourth study25 reported a signifi-
cant decrease in daily symptom score vs placebo
(Po0:05), but baseline values were higher in the
active treatment group. However, weekly scores
were significantly higher in the active treatment
group compared with placebo at week 4 (Po0:05),
but no difference was observed at later time points.
Laser acupuncture versus sham laser
acupuncture
These two studies19,20 did not detect significant
differences for lung function or symptom scores. No
difference in medication usage was reported in one
of these studies.19
Needle acupuncture versus sham laser
acupuncture
No significant difference was observed between
treatment and control groups for morning peak flow
or medication usage at 90 days.28
Discussion
This review highlights the fact that any trial of
acupuncture is inherently complex, and that many
different parameters need to be controlled for and
investigated. It could be questioned whether the
acupuncture used in the studies is representative of
that used in practice. Acupuncture often comes as
part of a package of care that includes diet and
herbal medicines, and it may not use a ‘‘standar-
dized’’ (i.e. pre-specified points) treatment strat-
egy. Adherence to the Standards for Reporting
Interventions in Controlled Trials of Acupuncture
guidelines31 could improve the validity of future
clinical trials.
There is a lack of evidence that short-term (1–12
weeks) acupuncture treatment has a significant
effect on the course of asthma when used in
conjunction with drug-maintenance treatment.
However, in usual practice, acupuncture therapy
may last longer than a 12-week course. Some
studies did report significant positive changes in
subjective parameters and medication use, and we
cannot exclude the possibility that some patients
with asthma may benefit from acupuncture.
The homeopathy review
Method
For the homeopathy review, we searched the
Asthma and Wheez* database of the Cochrane
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Airways Group for all trials including the word
homoeop* and homeop*. Additionally, we checked
the trial database of the initiative for a Cochrane
Complementary Medicine Field, the databases of
the Glasgow Homeopathic Library (Scotland), the
Centre for Complementary Medicine Research
(University of Munich, Germany), and the reference
lists of published reviews and papers.
Results
Differences in the interventions used in the trials
raised many questions concerning how to analyse
the findings of the studies. The studies could be
divided into the following categories: (1) Indivi-
dualized and formula; the approach to treatment
differs sufficiently between these two to merit
separation. This division would be helpful in
addressing the question of package of care, as that
associated with ‘‘individualized’’ differs greatly
from that provided with ‘‘formula’’ homeopathy,
which by its very nature is generic; (2) adults and
children; and (3) homeopathy and isopathy. Six
trials were included,32–37 detailed in Table 2.
All of the included studies were described as
randomized, double-blind, placebo-controlled,
parallel group trials. Diagnosis was variously de-
fined in terms of respiratory function,32 symp-
toms,33 clinical history and spirometry,34 clinical
history, spirometry and medication usage,35 lung
function, symptoms and medication usage,36 and
general practitioner diagnosis and medication pre-
scription.37
Participants suffered from mild-to-moderate
asthma37 or mixed severity (mild to severe).33,36
No attempt was made to grade severity in three of
the studies.32,34,35
Two studies recruited children only (of 1–12
years33 or 4–16 years37). The other four studies
recruited adults only (416 years;32 24–48 years;34
36–70 years;35 18–55 years36). Two studies32,36 used
allergen-based homeopathic treatments (isopathy).
No details were given in one of the studies33 on
the use of concomitant therapies. Most participants
in all the remaining studies were described as
taking medication to control their asthma.
Interventions
Active treatment was compared with placebo as an
adjunct to usual care in all of the studies. Four
studies used homeopathic dilutions, either single
remedies (Blatta officianalis C633), individualized
remedies (classical homeopathy37), or a standar-
dized combination (Engystol N containing Vincetox-
in D6/D10/D30 and sulfur D4/D10;34 and Asthma H
containing 14 different potencies of either D3, D4,
D5 or D635). Two studies32,36 used isopathy, both to
30C. Duration of treatment in the studies ranged
from 1 day36 (plus 16-week follow-up) to 1 year37
(with up to six consultations over 1 year).
Methodological quality of included studies
The overall study quality was deemed to be mixed
(see Table 2 for Jadad17 scores). All studies were
double-blind.
Although the aim of the review was to establish
the efficacy of homeopathy compared with place-
bo, all the studies administered homeopathic
treatment in addition to usual care. In most
instances, this was in addition to steroids or b2-
agonists. The effects of these medications may
have confounded potential benefits of homeopathy.
The reviewers felt that, across the studies, the
severity of asthma was largely mild to moderate.
This limits the applicability of this review to
patients with more severe asthma.
Owing to the heterogeneity of trials (in terms of
patients, interventions, and outcome assessment),
quantitative meta-analysis of the studies was
limited. We have only been able to assess homeo-
pathic treatments in addition to usual care.
Formula homeopathy versus placebo (in
addition to usual care)
One study32 found that the severity of symptoms
quantified by a daily visual analogue scale differed
significantly between the groups (P ¼ 0:003). No
significant difference was observed for peak ex-
piratory flow rate. Another study36 reported no
significant difference between treatment and con-
trol either after treatment or at 15-weeks follow-
up.
The data for morning peak expiratory flow could
not be pooled because of differences in the studies.
One study34 reported a significant difference
between homeopathy and control in favour of
homeopathy (no P value reported). Another study36
reported no significant difference after treatment
and at 15-week follow-up.
The reported FEV1 data could be pooled for two
of the studies.35,36 No significant difference was
observed (0.06 l; 95% CI 0.17 to 0.04). One
study32 assessed the difference between the
medians with 95% confidence intervals. No signifi-
cant difference was detected.
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Table 2 Studies included in the homeopathy review.
Reference Design and study
schedule
Methodological
quality (Jadad
score)n
Participants Outcomes Results
Freitas et al.33 Parallel group: 6 months 1-2-1 69 Frequency, duration and
intensity of bronchiospastic
episodes and a score
combining these three
measures. Lung function or
medication used does not
seem to have been
documented
No significant difference
was reported
Lewith et al.36 Parallel group: 4 weeks
run-in, 1 day treatment,
16 weeks follow-up
2-2-1 242 Lung function, medication
use, subjective symptoms
No difference in effect
found
Matusiewicz et al.34 Parallel group: 6 months 0-1-0 40 Lung function, medication
use, granulocyte function
‘‘Clear difference’’
reported
Matusiewicz et al.35 Parallel group: 9 months 1-1-0 84 Lung function, medication
use, immune system
functioning
Significant effect reported
in terms of medication use,
immune functioning, global
rating and number of
infections
Reilly et al.32 Parallel group: 4 weeks
placebo run-in and pre-
randomization
qualification period, 4
weeks treatment phase,
4 weeks optional follow-
up
1-2-1 28 Predefined main outcome
measure was the change of
subjective symptoms
measured on a 100mm visual
analogue scale. Additional
outcomes were lung function
and a numerical symptom
scale
Significant difference
found for severity of
symptom reporting
White et al.37 Parallel group: 52 weeks
of treatment, followed-
up at end of this period
2-2-1 93 Lung function at 4, 8 and 52
weeks (only reported at 52
weeks); quality of life
No significant difference
was reported
nJadad scores17 reflect the points awarded for the three component domains in the order of: randomization (0, 1 or 2), blinding (0, 1 or 2) and withdrawals (0 or 1).
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One study34 reported that there was a ‘‘clear
difference’’ between treatment and control, but no
statistical analysis was presented.
For FVC, no data could be pooled due to
differences in the studies. One study32 reported a
significant difference between the medians of the
groups (P ¼ 0:03). Another study34 reported a
‘‘clear difference’’ of 1.3 L, but again the results
of statistical tests were not reported. A third
study35 reported no significant differences in the
treatment group compared with control.
Medication usage
Two studies34,35 reported steroid usage. One of
them34 showed a ‘‘clear difference’’ between
treatment and control in terms of oral steroid use
(no P value reported). The other study35 reported
inhaled triamcinolone usage with treatment lead-
ing to a significant reduction in medication use
(Po0:01). No significant difference was reported in
bronchodilator usage after treatment or at 15-week
follow-up in a third study.36
Exacerbations
One study33 measured intensity, frequency and
duration of exacerbations in 86 children. No
significant difference was reported between the
groups in terms of intensity, frequency and duration
of exacerbations.
Individualized homeopathy versus placebo
(in addition to usual care)
One study measured individualized homeopathy.37
No significant difference was found between treat-
ment and control on symptoms, lung function,
quality of life, medication usage, global assess-
ment, and adverse effects.
Discussion
There did seem to be substantial differences
between the studies in terms of the package of
care provided. For example, in one study,37 there
was extensive telephone contact and changes in
remedy in addition to six consultations. It is
difficult to see how this can be assessed alongside
some of the less extensive ‘‘one off’’ treatments
offered in two of the studies.32,36
The currently available evidence makes it diffi-
cult to reliably assess the possible role of homeop-
athy in the treatment of asthma. We did not have
enough information to explore the effects of
separate remedies and potencies. Although the
scientific rationale behind homeopathy remains
unproven, non-specific benefits associated with a
‘‘holistic’’ package of care may exist. The effect of
homeopathy on asthma has yet to be proven in a
randomized study.
Conclusion
There is currently not enough good evidence to
recommend either acupuncture or homeopathy
in the management of asthma as a front-line
therapy. Nevertheless, the holistic approach
adopted by the trialists featured in these reviews
to patient care may make such alternative treat-
ments appealing to patients and their carers. More
research into both of these treatments is war-
ranted, paying particular attention to the way
these therapies are practiced.
The ‘‘package of care’’ issue in future trials is an
important one and applies to both acupuncture and
homeopathy. Acupuncture in practice is often one
aspect of a complex package of treatments. In the
absence of a scientific rationale for homeopathy,
some would argue that any observed effect cannot
be seen outside the context of the entire treatment
package, which consists of one-on-one, in depth,
‘‘holistic’’ consultation, administration of homeo-
pathic treatment, and follow-up. Until studies can
adequately estimate the effect of a ‘‘package of
care’’, the effects of these two alternative treat-
ment strategies will be difficult to quantify and
qualify. Studies conducted with two control treat-
ment groups (i.e. one arm that receives the
package and a placebo intervention, and another
that only receives the placebo intervention) might
offer some useful insights into patient expectations
of this type of care, and how they respond to close
attention from qualified specialists.
Practice points
* There is not enough evidence to recom-
mend the use of acupuncture in the
treatment of asthma.
* An open-minded approach, however, is
recommended with complementary treat-
ments to encourage disclosure and ap-
preciate that the holistic approach often
used with these types of therapies can
appeal and be of some benefit.
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Research directions
* Future research could investigate the im-
portance of the ‘‘package of care’’.
References
1. Janson C, Anto J, Burney P, et al. The European community
respiratory health survey II: what are the main results so far?
Eur Respir J 2001;18:598–611.
2. House of Lords Science and Technology Committee. Com-
plementary and alternative medicine, vol. 6. London:
HMSO; 2000.
3. Eisenberg DM, Davis RB, Ettner SL, et al. Trends in
alternative medicine use in the United States, 1990–1997:
results of a follow-up national survey. JAMA 1998;280:1569–
75.
4. Sirois FM, Gick ML. An investigation of the health beliefs and
motivations of complementary medicine clients. Soc Sci Med
2002;55:1025–37.
5. Thorne S, Paterson B, Russell C, Schultz A. Complementary/
alternative medicine in chronic illness as informed self-care
decision making. Int J Nurs Stud 2002;39:671–83.
6. Blanc PD, Trupin L, Earnest G, et al. Alternative therapies
among adults with a reported diagnosis of asthma or
rhinosinusitis. Chest 2001;120:1461–7.
7. Green S, Buchbinder R, Barnsley L, et al. Acupuncture for
lateral elbow pain (Cochrane Review). In: The Cochrane
library, Issue 3. Oxford: Update Software; 2003.
8. Knipschild P, Kleijnen J, ter Riet G. Belief in the efficacy of
alternative medicine among general practitioners in the
Netherlands. Soc Sci Med 1990;31:625–6.
9. Querfurt H. Alternative Behandlungsweisen aus der Sicht der
pneumologischen Praxis. Atemwegs Lungenkr 1995;21:11–8.
10. Vandenbroucke JP. Homoeopathy trials: going nowhere.
Lancet 1997;350:824.
11. Berezin AA. Isotopical positional correlations as a possible
model for Benveniste experiments. Med Hypotheses
1990;31:43–5.
12. Anagnostatos GS. Small water clusters (clathrates) in the
homoeopathic preparation process. In: Endler PC, Schulte J,
editors. Ultra high dilutionFphysiology and physics. Dor-
drecht: Kluwer Academic Publications; 1994. p. 121–8.
13. del Giudice E. Is the ‘‘memory of water’’ a physical
impossibility? In: Endler PC, Schulte J, editors. Ultra high
dilutionFphysiology and physics. Dordrecht: Kluwer Aca-
demic Publications; 1994. p. 117–20.
14. Lo SY, Lo A, Chong LW, Tianzhang L, Hua LH, Geng K. Physical
properties of water with I–E structures. Mod Phys Lett B
1996;10:921–30.
15. McCarney RW, Brinkhaus B, Lasserson TJ, Linde K. Acupunc-
ture for chronic asthma (Cochrane Review). In: The
Cochrane library, Issue 1. Oxford: Update Software; 2004.
16. McCarney RW, Linde K, Lasserson TJ. Homeopathy for
chronic asthma (Cochrane Review). In: The Cochrane
library, Issue 1. Oxford: Update Software; 2004.
17. Jadad AR, Moore RA, Carrol D, et al. Assessing the quality of
reports of randomized clinical trials: is blinding necessary?
Control Clin Trials 1996;17:1–12.
18. American Thoracic Society. Standards for the diagnosis,
care of patients with chronic obstructive pulmonary
disease (COPD) and asthma. Am Rev Respir Dis 1985;136:
228–9.
19. Tandon MK, Soh PFT, Wood AT. Acupuncture for bronchial
asthma? A double-blind crossover study. Med J Aust
1991;154:409–12.
20. Hirsch D, Leupold W. Plazebo-kontrollierte Doppelblindstu-
die zur Wirkung der Laserakupunktur beim kindlichen
Asthma bronchiale. Atemwegs Lungenkr 1994;20:701–5.
21. NHLBI/WHO Workshop. www.ginasthma.com, 2nd ed. Wa-
shington: NIH Publication; 2002.
22. Medici TC, Grebski E, Wu J, Hinz G, Wuthrich B. Acupuncture
and broncial asthma: a long-term randomized study of the
effects of real versus sham acupuncture compared to
controls in patients with bronchial asthma. J Altern
Complement Med 2002;8:737–50.
23. Joos S, Schott C, Zou H, Daniel V, Martin E. Immunomodu-
latory effects of acupuncture in the treatment of allergic
asthma: a randomized controlled study. J Altern Comple-
ment Med 2000;6:519–25.
24. Mitchell P, Wells JE. Acupuncture for chronic asthma: a
controlled trial with six months follow-up. Am J Acupunc-
ture 1989;17:5–13.
25. Christensen PA, Laursen LC, Taudorf E, St .orensen SC, Weeke
B. Acupuncture and bronchial asthma. Allergy 1984;39:
379–85.
26. Tashkin DP, Kroening RJ, Bresler DE, Simmons M, Coulson AH,
Kerschner H. A controlled trial of real and simulated
acupuncture in the management of chronic asthma. J
Allergy Clin Immunol 1985;76:855–64.
27. Biernacki W, Peake MD. Acupuncture in the treatment of
stable asthma. Respir Med 1998;92:1142–5.
28. Malmstr.om M, Ahlner J, Carlsson C, Schmekel B. No effect of
chinese acupuncture on isocapnic hyperventilation with cold
air in asthmatics, measured with impulse oscillometry.
Acupunct Med 2002;20:80–7.
29. Shapira MY, Berkman N, Ben-David G, Avital A, Bardach E,
Breuer R. Short-term acupuncture therapy is of no benefit in
patients with moderate persistent asthma. Chest
2002;121:1396–400.
30. Dias PLR, Subramaniam S, Lionel NDW. Effects of acupunc-
ture in bronchial asthma: preliminary communication. J R
Soc Med 1982;75:245–8.
31. MacPherson H, White A, Cummings M, Jobst K, Rose K,
Niemtzow R. Standards for reporting interventions in
controlled trials of acupuncture: the stricta recommenda-
tions. Complement Ther Med 2001;9:246–9.
32. Reilly D, Taylor MA, Beattie NGM, et al. Is evidence for
homoeopathy reproducible? Lancet 1994;344:1601–6.
33. Freitas LAS, Goldenstein E, Sanna OM. The indirect doctor-
patient relationship and the homeopathic treatment of
asthma in children. Rev Homeopatia 1995;60:26–31.
34. Matusiewicz R. Wirksamkeit von Engystol N bei Bronchia-
lasthma unter kortikoidabh.angiger Therapie. Biol Med
1995;24:242–6.
35. Matusiewicz R, Wasniewski J, Sterna-Bazanska A, Hulsberg
M. Behandlung des chronischen asthma bronchiale mit
einem homoopathischen komplexmittel. EHK 1999;6:
367–74.
36. Lewith GT, Watkins AD, Hyland ME, et al. Use of ultra-
molecular potencies of allergen to treat asthmatic people
allergic to house dust mite: double blind randomised
controlled clinical trial. BMJ 2002;324:1–5.
37. White A, Slade P, Hunt C, Hart A, Ernst E. Individualised
homeopathy as an adjunct in the treatment of childhood
asthma: a randomised placebo controlled trial. Thorax
2003;58:317–21.
ARTICLE IN PRESS
696 R.W. McCarney et al.
